Intravitreal injection of bevacizumab (Avastin) has been reported as a supportive measure in aggressive posterior retinopathy of prematurity.
Intravitrealna injekcija bevacizumaba (Avastin) je zabilježena kao potporna mjera u agresivnoj stražnjoj prematurnoj retinopatiji.